If you are living with abdominal obesity, high blood pressure, impaired fasting blood sugars and high cholesterol levels your kidneys, your liver and heart can all be affected. When one organ is affected, it can have a knock-on effect on others. This is called the Cardio-renal-metabolic (CaReMe) syndrome.
The CaReMe service is one of the first in the country to assess and treat people holistically to prevent progression of cardiovascular disease and support people to live well. This has now been established as standard practice. It is part of the provisions provided by the InnoMeds team.
What is the service and who is it for?
Dr Khatib, National Specialty Advisor for cardiovascular disease prevention, NHS England leads the innovative CardioRenal Metabolic (CaReMe) Medicines Optimisation service at the Cardio-Respiratory clinical service unit at Leeds Teaching Hospitals.
The service facilitates access and use of innovative therapies and a person-centred approach to reduce the impact of cardiovascular disease. The multidisciplinary team includes cardiologists, pharmacists, nurses, researchers, diabetologists, amongst others and spans across secondary and primary care. It is highly regarded and has won several awards.
The InnoMeds team works hard to provide innovative services through established patient clinics. The team actively monitors and commences preventative therapies for those living with an increased risk of cardiovascular disease. For example, people discharged from hospital after a cardiovascular event will be closely monitored by the team’s medicines optimisation service.
The InnoMeds team aims to provide support to patients in Leeds and to establishing a national model of best practice when it comes to cardiovascular care. An important part of this work is research, which is shared through conferences, publications and the Leeds NHS Research Website Section.